References
- Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117:850–858. doi: 10.1172/JCI30920
- Piccin A. Do we need to test blood donors for sickle cell anaemia? Blood Transfus. 2010;8:137–138.
- Stuart MJ, Nagel RL. Sickle-cell disease. The Lancet 2004;364:1343–1360. Available from: http://www.sciencedirect.com/science/article/pii/S0140673604171924. doi: 10.1016/S0140-6736(04)17192-4
- Belcher JD, Beckman JD, Balla G, et al. Heme degradation and vascular injury. Antioxid Redox Signal. 2010;12:233–248. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 2821146&tool = pmcentrez&rendertype = abstract. doi: 10.1089/ars.2009.2822
- Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64:72–80. doi: 10.1002/iub.584
- Osarogiagbon UR, Choong S, Belcher JD, et al. Reperfusion injury pathophysiology in sickle transgenic mice. Blood. 2000;96:314–320.
- Aslan M, Thornley-Brown D, Freeman B. Reactive species in sickle cell disease. Ann N Y Acad Sci. 2000;899:375–391. doi: 10.1111/j.1749-6632.2000.tb06201.x
- Magalhães SMM. Oxidative status in sickle cell anemia. Rev Bras Hematol Hemoter. 2011;33:177–178. Available from: http://www.rbhh.org/?doi = 10.5581/1516-8484.20110049. doi: 10.5581/1516-8484.20110049
- Hebbel RP, Osarogiagbon R, Kaul D. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation 2009;11:129–151. Available from: http://www.tandfonline.com/doi/abs/10.1080/10739680490278402. doi: 10.1080/mic.11.2.129.151
- Hebbel RP, Morgan WT, Eaton JW, et al. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci U S A. 1988;85:237–241. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 279519&tool = pmcentrez&rendertype = abstract. doi: 10.1073/pnas.85.1.237
- Ramos CL, Pou S, Britigan BE, et al. Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J Biol Chem [Internet]. 1992;267:8307–8312. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1314821.
- Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33:1–16. doi: 10.1080/03630260802625709
- Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: a state of nitric oxide resistance. Free Radic Biol Med. 2008;44:1506–1528. doi: 10.1016/j.freeradbiomed.2008.01.008
- World Health Organization. Constitution of the world health organization [Internet]. Basic Doc. Forthy-fifth Ed. 2006. Available from: http://www.who.int/en.
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3
- Myhre O, Andersen JM, Aarnes H, et al. Evaluation of the probes 2′,7′-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation. Biochem Pharmacol. 2003;10:1575–1582. doi: 10.1016/S0006-2952(03)00083-2
- Jentzsch aM, Bachmann H, Furst P, et al. Improved analysis of malondialdehyde in human body fluids. Free Radic Biol Med. 1996;20:251–256. doi: 10.1016/0891-5849(95)02043-8
- Resnick AZ, Packer K. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzym. 1994;233:357–363. doi: 10.1016/S0076-6879(94)33041-7
- Levine RL, Williams JA, Stadtman EP, et al. Determination of carbonyl groups in oxidized proteins. Methods Enzym. 1994;233:346–357. doi: 10.1016/S0076-6879(94)33040-9
- Boyne AF, Ellman GL. A methodology for analysis of tissue sulfhydryl components. Anal Biochem. 1972;46:639–653. doi: 10.1016/0003-2697(72)90335-1
- Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77. Available from: http://www.sciencedirect.com/science/article/pii/0003986159900906. doi: 10.1016/0003-9861(59)90090-6
- Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol. 1985;113:484–490. doi: 10.1016/S0076-6879(85)13062-4
- Nelson DP, Kiesow LA. Enthalpy of decomposition of hydrogen peroxide by catalase at 25°C (with molar extinction coefficients of H2O2 solutions in the UV). Anal Biochem. 1972;49:474–478. doi: 10.1016/0003-2697(72)90451-4
- Ellman GL, Courtney KD, Andres V, et al. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95. doi: 10.1016/0006-2952(61)90145-9
- Rocha JBT, Emanuelli T, Pereira ME. Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiol Exp (Wars). 1993;53:431–437.
- Metcalf J, Gallin JI, Nauseef WM, et al. Root, laboratory manual of neutrophil function. New York: Raven Press; 1986.
- Kayyali US, Moore TB, Randall JC, et al. Neurotoxic esterase (NTE) assay: optimized conditions based on detergent-induced shifts in the phenol/4-aminoantipyrine chromophore spectrum. J Anal Toxicol. 1991;15:86–89. doi: 10.1093/jat/15.2.86
- Sh N. The correlation between xanthine oxidase, lactate dehydrogenase and nitric oxide levels in sera of patients with. Eur J Pharma Med Res. 2016;3:66–71.
- Voelter W, Zech K, Arnold P, et al. Determination of selected pyrimidines, purines and their metabolites in serum and urine by reversed-phase ion-pair chromatography. J Chromatogr A. 1980;199:345–354. Available from: http://linkinghub.elsevier.com/retrieve/pii/S002196730191386X. doi: 10.1016/S0021-9673(01)91386-X
- Mayr S, Buchner A, Erdfelder E, et al. A short tutorial of GPower. Tutor Quant Methods Psychol. 2007;3:51–59. Available from: http://www.gpower.hhu.de/fileadmin/redaktion/Fakultaeten/Mathematisch-Naturwissenschaftliche_Fakultaet/Psychologie/AAP/gpower/GPowerShortTutorial.pdf. doi: 10.20982/tqmp.03.2.p051
- Bunn HF, Noguchi CT, Hofrichter J, et al. Molecular and cellular pathogenesis of hemoglobin SC disease. Proc Natl Acad Sci U S A. 1982;79:7527–7531. doi: 10.1073/pnas.79.23.7527
- Uzunova VV, Pan W, Galkin O, et al. Free heme and the polymerization of sickle cell hemoglobin. Biophys J. 2010;99:1976–1985. doi: 10.1016/j.bpj.2010.07.024
- Klings ES, Farber HW. Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease. Respir Res. 2001;2:280–285. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 59517&tool = pmcentrez&rendertype = abstract. doi: 10.1186/rr70
- Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8:1383–1389. doi: 10.1038/nm1202-799
- Gladwin MT, Kanias T, Kim-Shapiro DB. Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest. 2012;122:1205–1208. doi: 10.1172/JCI62972
- Hierso R, Waltz X, Mora P, et al. Effects of oxidative stress on red blood cell rheology in sickle cell patients. Br J Haematol. 2014;166:601–606. doi: 10.1111/bjh.12912
- Szocs, K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys. 2004;23:265–295.
- Asakura T, Onishi T, Friedman S, et al. Abnormal precipitation of oxyhemoglobin S by mechanical shaking. Proc Natl Acad Sci U S A. 1974;71:1594–1598. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 388282&tool = pmcentrez&rendertype = abstract. doi: 10.1073/pnas.71.5.1594
- Hebbel RP, Ney PA, Foker W. Autoxidation, dehydration, and adhesivity may be related abnormalities of sickle erythrocytes. Am J Physiol. 1989;256:C579–C583.
- Marva E, Hebbel RP. Denaturing interaction between sickle hemoglobin and phosphatidylserine liposomes. Blood [Internet]. 1994;83:242–249. Available from: http://www.bloodjournal.org/content/83/1/242.abstract.
- Leonard SS, Harris GK, Shi X. Metal-induced oxidative stress and signal transduction. Free Radic Biol Med. 2004;37:1921–1942. doi: 10.1016/j.freeradbiomed.2004.09.010
- Omura T. Heme-thiolate proteins. Biochem Biophys Res Commun. 2005;338:404–409. doi: 10.1016/j.bbrc.2005.08.267
- Zerez CR, Lachant NA, Lee SJ, et al. Decreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease. Blood [Internet]. 1988;71:512–515. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3337912.
- Lachant NA, Davidson WD, Tanaka KR. Impaired pentose phosphate shunt function in sickle cell disease: a potential mechanism for increased Heinz body formation and membrane lipid peroxidation. Am J Hematol. 1983;15:1–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6881134. doi: 10.1002/ajh.2830150102
- Rank BH, Carlsson J, Hebbel RP. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest. 1985;75:1531–1537. doi: 10.1172/JCI111857
- Hebbel RP, Eaton JW, Balasingam M, et al. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70:1253–1259. doi: 10.1172/JCI110724
- Fewell SW, Travers KJ, Jonathan S, et al. The action of molecular chaperones in the early secretory pathway. Annu Rev Genet. 2001;35:149–191. doi: 10.1146/annurev.genet.35.102401.090313
- Somjee SS, Warrier RP, Thomson JL, et al. Advanced glycation end-products in sickle cell anaemia. Br J Haematol. 2005;128:112–118. doi: 10.1111/j.1365-2141.2004.05274.x
- Reid M, Badaloo A, Forrester T, et al. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab. 2006;291:E73–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16434557. doi: 10.1152/ajpendo.00287.2005
- Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999;27:922–935. doi: 10.1016/S0891-5849(99)00176-8
- Wu G, Fang Y-Z, Yang S, et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489–492. Available from: http://jn.nutrition.org/content/134/3/489.abstract.
- Tatum VL, Chow CK. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radic Res. 1996;25:133–139. doi: 10.3109/10715769609149918
- Lu Q, Jourd’heuil FL, Jourd’heuil D. Redox control of G1/S cell cycle regulators during nitric oxide-mediated cell cycle arrest. J Cell Physiol. 2007;212:827–839. doi: 10.1002/jcp.21079
- Davies MJ, Fu S, Wang H, et al. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med. 1999;27:1151–1163. doi: 10.1016/S0891-5849(99)00206-3
- Himmelfarb J, McMonagle E, McMenamin E. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int. 2000;58:2571–2578. doi: 10.1046/j.1523-1755.2000.00443.x
- Lu N, Chen W, Peng YY. Effects of glutathione, Trolox and desferrioxamine on hemoglobin-induced protein oxidative damage: anti-oxidant or pro-oxidant? Eur J Pharmacol. 2011;659:95–101. doi: 10.1016/j.ejphar.2011.03.009
- Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329:23–38. doi: 10.1016/S0009-8981(03)00003-2
- Levine RL, Wehr N, Williams JA, et al. Determination of carbonyl groups in oxidized proteins. Methods Mol Biol. 2000;99:15–24.
- Carrell RW, Winterbourn CC, Rachmilewitz EA. Activated oxygen and hemolysis. Br J Haematol. 1975;30:259–264. doi: 10.1111/j.1365-2141.1975.tb00540.x
- Hundekar P, Suryakar A, Karnik A, et al. Antioxidant status and lipid peroxidation in sickle cell anaemia antioxidant status and lipid peroxidation in sickle cell anaemia. Biomed Res. 2010:21(4):461–464.
- Titus J, Chari S, Gupta M, et al. Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia. Indian J Clin Biochem. 2004;19:168–172. doi: 10.1007/BF02894279
- Das SK, Nair RC. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol. 1980;44:87–92. doi: 10.1111/j.1365-2141.1980.tb01186.x
- Al-Naama LM, Hassan MK, Mehdi JK. Association of erythrocytes antioxidant enzymes and their cofactors with markers of oxidative stress in patients with sickle cell anemia. Qatar Med J. 2015;2015:14), Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 4719435&tool = pmcentrez&rendertype = abstract. doi: 10.5339/qmj.2015.14
- Chiu D, Lubin B Shohet SB. Peroxidative reactions in red cell biology. In: Pryor W, editor. Free radicals in biology. New York: Academic Press; 1982. p. 115–160.
- Jain SK. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem. 1984;259:3391–3394.
- Silva DGH, Belini Junior E, De Almeida EA, et al. Oxidative stress in sickle cell disease: An overview of erythrocyte redox metabolism and current antioxidant therapeutic strategies. Free Radic Biol Med. 2013;65:1101–1109. doi: 10.1016/j.freeradbiomed.2013.08.181
- Qujeq D, Rezvani T. Catalase (antioxidant enzyme) activity in streptozotocin-induced diabetic rats. Int J Diabetes Metab. 2007;15:22–24.
- Stanley P, Balcerzak MD, Wallace NJ. Erythrocyte catalase activity in thalassaemia. Eur J Haematol. 2009;3(4):245–256.
- Barbosa MC, de Jesus dos Santos TE, dos Santos TN, et al. The effect of a selective inhibitor of phosphodiesterase-9 on oxidative stress, inflammation and cytotoxicity in neutrophils from patients with sickle cell anaemia. Basic Clin Pharmacol Toxicol. 2015: 118(4):271–278. doi: 10.1111/bcpt.12487
- Daak AA, Ghebremeskel K, Mariniello K, et al. Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients. Prostaglandins Leukot Essent Fat Acids. 2013;89:305–311. doi: 10.1016/j.plefa.2013.09.006
- Gizi A, Papassotiriou I, Apostolakou F, et al. Assessment of oxidative stress in patients with sickle cell disease: the glutathione system and the oxidant-antioxidant status. Blood Cells Mol Dis. 2011;46:220–225. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21334230. doi: 10.1016/j.bcmd.2011.01.002
- Massoulié J, Pezzementi L, Bon S, et al. Molecular and cellular biology of cholinesterases. Prog Neurobiol. 1993;41:31–91. doi: 10.1016/0301-0082(93)90040-Y
- Wiedner CDF. Effects of amphiphiles on structure and activity of human erythrocyte membrane acetylcholinesterase. Eur J Biochem. 1979;102:59–64. doi: 10.1111/j.1432-1033.1979.tb06262.x
- Layer PG and Willbold E. Novel functions of cholinesterases in development. Prog Histochem Cytochem. 1995;29:1–94.
- George ST, Balasubramanian AS. The identity of the serotonin-sensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel. Eur J Biochem. 1980;111:511–524. doi: 10.1111/j.1432-1033.1980.tb04967.x
- Frijhoff J, Winyard PG, Zarkovic N, et al. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal. 2015;23:1144–1170. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid = 4657513&tool = pmcentrez&rendertype = abstract. doi: 10.1089/ars.2015.6317
- Zhang H, Xu H, Weihrauch D, et al. Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. J Lipid Res. 2013;54:3009–3015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23956444. doi: 10.1194/jlr.M038281
- Aslan M, Freeman BA. Redox-dependent impairment of vascular function in sickle cell disease. Free Radic Biol Med. 2007;43:1469–1483. doi: 10.1016/j.freeradbiomed.2007.08.014
- Xu W, Chi L, Row BW, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126:313–323. doi: 10.1016/j.neuroscience.2004.03.055
- Yuan G, Adhikary G, McCormick A, et al. Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol. 2004;557:773–783. doi: 10.1113/jphysiol.2003.058503